Lv1
88 积分 2025-11-12 加入
Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic Db/Db mice
19天前
已完结
The relationship between muscle mass and fat content in body composition and non-alcoholic fatty liver disease in the Chinese general population: a cross-sectional study
1个月前
已完结
Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease
3个月前
已完结
Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease
3个月前
已完结
Oridonin Ameliorates Metabolic-Dysfunction-Associated Fatty Liver Disease by Inhibiting PANoptosis via Modulating SIRT2/NLRP3 Pathway
3个月前
已完结
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
3个月前
已完结
A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway
4个月前
已完结
Integration of multiple omics reveals key targets and cellular mechanisms for intervention in sarcopenia
4个月前
已完结
Liraglutide ameliorates early renal injury by the activation of renal FoxO1 in a type 2 diabetic kidney disease rat model
5个月前
已完结
Liraglutide reduces the apoptosis of feeding and appetite-suppressing neurons in the hypothalamus of obese rats association with the PI3K/AKT/Foxo1 pathway
5个月前
已关闭
皖公网安备34019202002308
